Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032.
Department of Medicine, Columbia University Medical Center, New York, NY 10032.
J Immunol. 2018 Mar 1;200(5):1561-1569. doi: 10.4049/jimmunol.1700257. Epub 2018 Jan 17.
Asthma is a chronic inflammatory disease mediated by allergen-specific CD4 T cells that promote lung inflammation through recruitment of cellular effectors into the lung. A subset of lung T cells can persist as tissue-resident memory T cells (TRMs) following infection and allergen induction, although the generation and role of TRM in asthma persistence and pathogenesis remain unclear. In this study, we used a mouse model of chronic exposure to intranasal house dust mite (HDM) extract to dissect how lung TRMs are generated and function in the persistence and pathogenesis of allergic airway disease. We demonstrate that both CD4 and CD8 T cells infiltrate into the lung tissue during acute HDM exposure; however, only CD4 TRMs, and not CD8 TRMs, persist long term following cessation of HDM administration. Lung CD4 TRMs are localized around airways and are rapidly reactivated upon allergen re-exposure accompanied by the rapid induction of airway hyperresponsiveness independent of circulating T cells. Lung CD4 TRM activation to HDM challenge is also accompanied by increased recruitment and activation of dendritic cells in the lungs. Our results indicate that lung CD4 TRMs can perpetuate allergen-specific sensitization and direct early inflammatory signals that promote rapid lung pathology, suggesting that targeting lung CD4 TRMs could have therapeutic benefit in alleviating recurrent asthma episodes.
哮喘是一种由过敏原特异性 CD4 T 细胞介导的慢性炎症性疾病,通过募集细胞效应物进入肺部促进肺部炎症。在感染和过敏原诱导后,一小部分肺 T 细胞可以作为组织驻留记忆 T 细胞(TRM)持续存在,尽管 TRM 在哮喘持续存在和发病机制中的产生和作用仍不清楚。在这项研究中,我们使用了一种慢性暴露于鼻腔内屋尘螨(HDM)提取物的小鼠模型,以剖析肺 TRM 如何在过敏性气道疾病的持续存在和发病机制中产生和发挥作用。我们证明,在急性 HDM 暴露期间,CD4 和 CD8 T 细胞都浸润到肺组织中;然而,只有 CD4 TRM,而不是 CD8 TRM,在停止 HDM 给药后长期持续存在。肺 CD4 TRM 定位于气道周围,在过敏原再次暴露时迅速被激活,伴有气道高反应性的快速诱导,而不依赖于循环 T 细胞。肺 CD4 TRM 对 HDM 挑战的激活也伴随着肺部树突状细胞的募集和激活增加。我们的研究结果表明,肺 CD4 TRM 可以延续过敏原特异性致敏,并直接促进早期炎症信号,从而促进快速的肺部病理学,这表明靶向肺 CD4 TRM 可能在缓解复发性哮喘发作方面具有治疗益处。